These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19654598)

  • 1. Ulcers: adjuvant PPIs to prevent major ulcer bleeds.
    Leodolter A; Labenz J
    Nat Rev Gastroenterol Hepatol; 2009 Aug; 6(8):446-7. PubMed ID: 19654598
    [No Abstract]   [Full Text] [Related]  

  • 2. Gastrointestinal bleeding: adjuvant pharmacotherapy for peptic ulcer bleeding.
    Hsu YC; Lin HJ
    Nat Rev Gastroenterol Hepatol; 2009 Aug; 6(8):450-2. PubMed ID: 19654601
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of bleeding recurrence in peptic ulcer by Helicobacter pylori eradication].
    Gisbert JP
    Gastroenterol Hepatol; 2005 Nov; 28(9):567-75. PubMed ID: 16277966
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of omeprazole and placebo for bleeding peptic ulcer.
    Srinath C
    Trop Gastroenterol; 1997; 18(3):115-6. PubMed ID: 9385855
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous omeprazole after endoscopic treatment of bleeding peptic ulcers.
    Palmer KR
    Gut; 2001 Nov; 49(5):610-1. PubMed ID: 11600458
    [No Abstract]   [Full Text] [Related]  

  • 6. Omeprazole for bleeding PUD: do we finally have evidence for effective medical therapy?
    Pedersen PJ; Bjorkman DJ
    Am J Gastroenterol; 1998 Sep; 93(9):1583-5. PubMed ID: 9732953
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness analysis: stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists.
    Barkun AN; Adam V; Martel M; Bardou M
    Value Health; 2013; 16(1):14-22. PubMed ID: 23337211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptic ulcer--current status.
    Brooks FP
    Clin Invest Med; 1987 May; 10(3):108-16. PubMed ID: 3113795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials.
    Scally B; Emberson JR; Spata E; Reith C; Davies K; Halls H; Holland L; Wilson K; Bhala N; Hawkey C; Hochberg M; Hunt R; Laine L; Lanas A; Patrono C; Baigent C
    Lancet Gastroenterol Hepatol; 2018 Apr; 3(4):231-241. PubMed ID: 29475806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreasing incidence of peptic ulcer complications after the introduction of the proton pump inhibitors, a study of the Swedish population from 1974-2002.
    Hermansson M; Ekedahl A; Ranstam J; Zilling T
    BMC Gastroenterol; 2009 Apr; 9():25. PubMed ID: 19379513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy.
    Lin HJ; Lo WC; Lee FY; Perng CL; Tseng GY
    Arch Intern Med; 1998 Jan; 158(1):54-8. PubMed ID: 9437379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guidelines for good practice: anti-ulcer agents, indications in the adult. French Agency for Health Safety of Health Products].
    Therapie; 1999; 54(5):509-17. PubMed ID: 10667082
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparing intravenous and oral proton pump inhibitor therapy for bleeding peptic ulcers following endoscopic management: a systematic review and meta-analysis.
    Tringali A; Manta R; Sica M; Bassotti G; Marmo R; Mutignani M
    Br J Clin Pharmacol; 2017 Aug; 83(8):1619-1635. PubMed ID: 28181291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory peptic ulcer disease.
    Napolitano L
    Gastroenterol Clin North Am; 2009 Jun; 38(2):267-88. PubMed ID: 19446258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent peptic ulcer disease in a pediatric patient with type 1 neurofibromatosis and primary ciliary dyskinesia.
    Lionetti E; Francavilla R; Ruggieri M; Di Stefano V; Principi MB; Pavone L
    Minerva Pediatr; 2009 Oct; 61(5):557-9. PubMed ID: 19794381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptic ulcer.
    Piper DW
    Aust N Z J Med; 1988 May; 18(3):237-44. PubMed ID: 3056364
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prognosing the gastroduodenal ulcer bleeding recurrence].
    Lebedev NV; Klimov AE; Sokolova PIu
    Khirurgiia (Mosk); 2012; (12):77-80. PubMed ID: 23323287
    [No Abstract]   [Full Text] [Related]  

  • 18. Stress ulcer prophylaxis in the intensive care unit.
    Krag M; Perner A; Møller MH
    Curr Opin Crit Care; 2016 Apr; 22(2):186-90. PubMed ID: 26849250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisecretory therapy for bleeding peptic ulcer.
    Peterson WL; Cook DJ
    JAMA; 1998 Sep; 280(10):877-8. PubMed ID: 9739959
    [No Abstract]   [Full Text] [Related]  

  • 20. [Is there any benefit in the use of ranitidine in hospitalized patients, under a minor regimen of stress, in the prophylaxis of peptic ulcer or gastrointestinal bleeding?].
    Holtz JV; Grandi LM; Ecclissato PR; Bernardo WM
    Rev Assoc Med Bras (1992); 2007; 53(6):476-7. PubMed ID: 18157352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.